Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q10910504> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q10910504 subject Q7211328.
- Q10910504 subject Q7240335.
- Q10910504 subject Q9052781.
- Q10910504 abstract "Gusperimus is an immunosuppressive drug. It is a derivative of the antitumor antibiotic spergualin, and inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells.Gusperimus was developed by Bristol-Myers Squibb. Currently, it is manufactured and sponsored for use as an orphan drug and for clinical studies by the Japanese company Euro Nippon Kayaku. The patent claim (see quotation) is that Gusperimus may be useful for a variety of hyperreactive inflammatory diseases such as autoimmune diseases. The drug is available in vials containing 100 mg each.There is little information about the pharmacokinetic properties of gusperimus.".
- Q10910504 thumbnail Gusperimus.svg?width=300.
- Q10910504 wikiPageExternalLink art00040.
- Q10910504 wikiPageExternalLink o034.htm.
- Q10910504 wikiPageExternalLink treatmentDetail.asp?treatmentID=858.
- Q10910504 wikiPageExternalLink nci_Gusperimus.
- Q10910504 wikiPageWikiLink Q1161568.
- Q10910504 wikiPageWikiLink Q1194520.
- Q10910504 wikiPageWikiLink Q1367466.
- Q10910504 wikiPageWikiLink Q1472.
- Q10910504 wikiPageWikiLink Q1765748.
- Q10910504 wikiPageWikiLink Q183309.
- Q10910504 wikiPageWikiLink Q187255.
- Q10910504 wikiPageWikiLink Q188297.
- Q10910504 wikiPageWikiLink Q188724.
- Q10910504 wikiPageWikiLink Q206901.
- Q10910504 wikiPageWikiLink Q214166.
- Q10910504 wikiPageWikiLink Q2457238.
- Q10910504 wikiPageWikiLink Q249619.
- Q10910504 wikiPageWikiLink Q266423.
- Q10910504 wikiPageWikiLink Q2742490.
- Q10910504 wikiPageWikiLink Q323936.
- Q10910504 wikiPageWikiLink Q3622439.
- Q10910504 wikiPageWikiLink Q367700.
- Q10910504 wikiPageWikiLink Q411648.
- Q10910504 wikiPageWikiLink Q416217.
- Q10910504 wikiPageWikiLink Q418834.
- Q10910504 wikiPageWikiLink Q420686.
- Q10910504 wikiPageWikiLink Q423088.
- Q10910504 wikiPageWikiLink Q424620.
- Q10910504 wikiPageWikiLink Q496812.
- Q10910504 wikiPageWikiLink Q5272302.
- Q10910504 wikiPageWikiLink Q546523.
- Q10910504 wikiPageWikiLink Q6402731.
- Q10910504 wikiPageWikiLink Q644318.
- Q10910504 wikiPageWikiLink Q7211328.
- Q10910504 wikiPageWikiLink Q7240335.
- Q10910504 wikiPageWikiLink Q8277.
- Q10910504 wikiPageWikiLink Q8880.
- Q10910504 wikiPageWikiLink Q9052781.
- Q10910504 wikiPageWikiLink Q974135.
- Q10910504 type ChemicalCompound.
- Q10910504 type ChemicalSubstance.
- Q10910504 type ChemicalObject.
- Q10910504 type Thing.
- Q10910504 type Q11173.
- Q10910504 comment "Gusperimus is an immunosuppressive drug. It is a derivative of the antitumor antibiotic spergualin, and inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells.Gusperimus was developed by Bristol-Myers Squibb.".
- Q10910504 label "Gusperimus".
- Q10910504 depiction Gusperimus.svg.